The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced OTC product boom; Faes Farma’s growth; and why prostate cancer remains a significant concern in the country. Colombia-Based…
The latest from the healthcare industry in Latin America, including an alarming OECD report about the decline of well-being in the region due to Covid-19, Bayer’s USD 350 million investment…
Medical devices are one of the most profitable niches in Colombian health. Marisol Sanchez, president of the Camara de Proveedores de Salud, notes that “the medical device sector correlated to…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion pharma market, announced a swathe of manufacturing investments in late 2019, taking its spending on plants and equipment in…
David Leclercq, general manager of Mundipharma Colombia, reveals his passion for both the Colombian affiliate and the welfare of the Colombian people and gives insight into operating a new pharmaceutical outfit in a highly transformative healthcare environment. You were appointed General Manager in Colombia back in 2014; what have been your main priorities since then? “Colombian pharmaceutical firms are very…
Guillermo Browne, General Manager at MSD Colombia, reveals the strategic importance of the Colombian affiliate, hosting a global data management centre and regional pharmacovigilance operations, while highlighting the company’s commitment…
Juan Carlos Mejia Hernandez, General Manager of Altadis Farmaceutica, a fresh entrant into the Colombian market, speaks about his strategies for advancing the educational system within the medical community by…
With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to penetrate the Colombian market. Inward investment from India, in particular, has been…
With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a destination of choice for multinationals, not only to set up shop in…
The latest from the fight against COVID-19 in Latin America, including J&J’s vaccine trials, issues surrounding Chinese-made diagnostic tests, Colombia’s vaccine manufacturing capacity, and potential compulsory licensing in Brazil. …
The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national COVID-19 vaccination programs, a new variant of the virus in Colombia, and the…
Below we highlight recent news in the Latin America region, focusing on Argentina, Colombia and Chile. Top stories cover the fight against COVID-19, economic uncertainty in the Mercosur region, and…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia, Brazil, and Mexico as well as legal and regulatory updates on the status of medical cannabis in the region.…
See our Cookie Privacy Policy Here